An Open Label Trial of TMS Therapy for Bipolar Depression
Public ClinicalTrials.gov record NCT02640950. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Transcranial Magnetic Stimulation (TMS) is an increasingly accepted neurostimulation- based treatment for major depressive disorder. While there is a growing anecdotal database supporting its use in bipolar depression the investigators propose to collect open label efficacy and safety data in a small population of patients with clinically verified bipolar disorder.
Study identification
- NCT ID
- NCT02640950
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 31 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2015
- Primary completion
- Jun 30, 2020
- Completion
- Jun 30, 2020
- Last update posted
- May 31, 2022
2015 – 2020
United States locations
- U.S. sites
- 2
- U.S. states
- 2
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sheppard Pratt Health System | Baltimore | Maryland | 21204 | — |
| Department of Psychiatry and Psychology, Mayo Clinic | Rochester | Minnesota | 55905 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Bipolar Depression trials
Other public records listing Bipolar Depression. Sorted by last update posted; newest first. Not a recommendation.
- NCT07745374: Safety and Feasibility of DBS for Bipolar Depression Recruiting
- NCT07172516: A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression) Recruiting
- NCT03349528: Probiotics to Prevent Relapse After Hospitalization for Bipolar Depression Active, not recruiting
- NCT03484494: Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression Active, not recruiting
- NCT04480918: University of Iowa Interventional Psychiatry Service Patient Registry Recruiting
- NCT03336918: Lithium Effects on the Brain's Functional and Structural Connectome in the Treatment of Bipolar Disorder Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02640950, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 31, 2022 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02640950 live on ClinicalTrials.gov.